The ABN AMBO report indicates successful clinical results will increase their valuation. Bioshares in their final publication for 2006 took profits on AVX and removed it from their model portfolio---it was however originally added at 15c IMHO good trial results coupled with what appears to be an improving sentiment towards biotech should see further share price appreciation---how much though is anyone's guess
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
